Published in J Surg Res on December 01, 1995
Changing the energy of an immune response. Am J Clin Exp Immunol (2013) 0.88
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med (1989) 4.69
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med (1990) 4.53
Substrate specificity determinants for casein kinase II as deduced from studies with synthetic peptides. J Biol Chem (1987) 3.04
Income inequality and population health. Soc Sci Med (1998) 2.80
Activation of casein kinase II in response to insulin and to epidermal growth factor. Proc Natl Acad Sci U S A (1987) 2.44
The British quasi-market in health care: a balance sheet of the evidence. J Health Serv Res Policy (2000) 2.24
Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology (1993) 2.20
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am J Clin Pathol (1995) 1.43
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg (1997) 1.41
Acceptance of hepatitis B vaccine among hospital workers. Am J Public Health (1986) 1.39
Idiopathic thrombocytopenic purpura during interferon-alpha 2B treatment for chronic hepatitis. Am J Gastroenterol (1994) 1.37
Conceptual and practical difficulties with the economic evaluation of health services developments. J Health Serv Res Policy (2000) 1.27
Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology (1983) 1.20
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther (1994) 1.20
Auditory sensitivity and song spectrum of the common canary (Serinus canarius). J Acoust Soc Am (1971) 1.16
Hemicelluloses of cell walls of a proso millet cell suspension culture. Plant Physiol (1985) 1.12
The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre. J Viral Hepat (2005) 1.08
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology (1998) 1.03
Treatment rates in patients with chronic hepatitis C after liver biopsy. J Viral Hepat (2006) 0.98
Contracting in the NHS quasi-market. Health Econ (1997) 0.92
Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group. J Viral Hepat (1994) 0.88
A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis. Hepatology (1985) 0.85
Adult presentation of Caroli's syndrome treated with orthotopic liver transplantation. Am J Gastroenterol (1997) 0.83
Interleukin-6 production by rat hepatocellular carcinoma cells is associated with metastatic potential but not with tumorigenicity. Arch Surg (1996) 0.82
Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin. Am J Clin Pathol (2000) 0.80
Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group. Hepatology (1996) 0.80
Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients. Liver Transpl Surg (1997) 0.80
Patterns of liver test abnormalities in patients with surgical sepsis. Am Surg (1991) 0.80
Transmission of hepatitis C: sexual, vertical or exclusively blood-borne? Hepatology (1992) 0.79
Hepatic Weber-Christian disease. Semin Liver Dis (2001) 0.79
Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Med Virol (1994) 0.79
Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group. J Hepatol (1990) 0.79
Low-level (PPB) determination of cisplatin in cleaning validation (rinse water) samples. II. A high-performance liquid chromatographic method. Drug Dev Ind Pharm (2000) 0.78
Fatal fungemia resulting from an infected transjugular intrahepatic portosystemic shunt stent. Am J Gastroenterol (1997) 0.78
Autoimmune hepatitis in a patient with sickle cell disease. Am J Gastroenterol (1996) 0.78
Effect of IL-6 overexpression on the metastatic potential of rat hepatocellular carcinoma cells. Ann Surg Oncol (1998) 0.78
Low-level (PPB) determination of cisplatin in cleaning validation (rinse water) samples. I. An atomic absorption spectrophotometric method. Drug Dev Ind Pharm (2000) 0.77
Hereditary hemochromatosis in liver transplantation. Liver Transpl Surg (1999) 0.77
Characteristic histologic triad in liver adjacent to metastatic neoplasm. Liver (1986) 0.77
Nodular regenerative hyperplasia of the liver in a patient with diabetes mellitus. Cancer (1982) 0.77
Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone. Am J Gastroenterol (2001) 0.77
Absence of hepatitis G virus within liver tissue of patients undergoing liver transplantation for cryptogenic cirrhosis. Transplantation (1999) 0.76
Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplant. Am J Gastroenterol (1998) 0.76
Long-term sequellae of acetaminophen-associated fulminant hepatic failure: relevance of early histology. Am J Gastroenterol (1988) 0.76
Acceptance of hepatitis B vaccine among hospital workers: a follow-up. Am J Public Health (1986) 0.75
The relationship between income inequality and population health. Soc Sci Med (1998) 0.75
Effects of penicillamine on serum immunoglobulins and immune complex-reactive material in primary biliary cirrhosis. Gastroenterology (1985) 0.75
Randomized controlled trial of quinacrine for the treatment of HBsAg-positive chronic hepatitis. Hepatology (1983) 0.75
The prevalence of hepatitis B surface antigen and antibody in home-reared individuals with Down syndrome. Res Dev Disabil (1991) 0.75
State of the art. Primary biliary cirrhosis and the immune system. Am J Gastroenterol (1979) 0.75
Psychiatric aspects of ageing. Gerontol Clin (Basel) (1968) 0.75
Does interferon precipitate rejection of liver allografts? Hepatology (1995) 0.75
Agranulocytosis associated with aprindine therapy. Arch Intern Med (1979) 0.75
Hemochromatosis associated with chronic cimetidine therapy? J Clin Gastroenterol (1981) 0.75